272 related articles for article (PubMed ID: 9660576)
1. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).
van Duijn CM; Delasnerie-Lauprêtre N; Masullo C; Zerr I; de Silva R; Wientjens DP; Brandel JP; Weber T; Bonavita V; Zeidler M; Alpérovitch A; Poser S; Granieri E; Hofman A; Will RG
Lancet; 1998 Apr; 351(9109):1081-5. PubMed ID: 9660576
[TBL] [Abstract][Full Text] [Related]
2. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.
Will RG; Alperovitch A; Poser S; Pocchiari M; Hofman A; Mitrova E; de Silva R; D'Alessandro M; Delasnerie-Laupretre N; Zerr I; van Duijn C
Ann Neurol; 1998 Jun; 43(6):763-7. PubMed ID: 9629846
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls.
Ward HJ; Everington D; Croes EA; Alperovitch A; Delasnerie-Lauprêtre N; Zerr I; Poser S; van Duijn CM
Neurology; 2002 Aug; 59(4):543-8. PubMed ID: 12196646
[TBL] [Abstract][Full Text] [Related]
4. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
Brandel JP; Peckeu L; Haïk S
Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies.
Wientjens DP; Davanipour Z; Hofman A; Kondo K; Matthews WB; Will RG; van Duijn CM
Neurology; 1996 May; 46(5):1287-91. PubMed ID: 8628468
[TBL] [Abstract][Full Text] [Related]
6. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
[TBL] [Abstract][Full Text] [Related]
7. Occupational risk factors for the sporadic form of Creutzfeldt-Jakob disease.
Cocco PL; Caperna A; Vinci F
Med Lav; 2003; 94(4):353-63. PubMed ID: 14526494
[TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
[TBL] [Abstract][Full Text] [Related]
9. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe.
EUROCJD Group
Rev Neurol (Paris); 2001 Jul; 157(6-7):633-7. PubMed ID: 11458182
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study.
Collins S; Law MG; Fletcher A; Boyd A; Kaldor J; Masters CL
Lancet; 1999 Feb; 353(9154):693-7. PubMed ID: 10073510
[TBL] [Abstract][Full Text] [Related]
11. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.
Zerr I; Brandel JP; Masullo C; Wientjens D; de Silva R; Zeidler M; Granieri E; Sampaolo S; van Duijn C; Delasnerie-Lauprêtre N; Will R; Poser S
J Clin Epidemiol; 2000 Jul; 53(7):747-54. PubMed ID: 10941953
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological surveillance of Creutzfeldt-Jakob in France].
Brandel JP; Salomon D; Capek I; Vaillant V; Alpérovitch A
Rev Neurol (Paris); 2009; 165(8-9):684-93. PubMed ID: 19467685
[TBL] [Abstract][Full Text] [Related]
13. Creutzfeldt-Jakob disease in health professionals in Slovakia.
Mitrová E; Belay G
Eur J Epidemiol; 2000 Apr; 16(4):353-5. PubMed ID: 10959943
[TBL] [Abstract][Full Text] [Related]
14. Risk of Creutzfeldt-Jakob disease in relation to animal spongiform encephalopathies: a collaborative study in Europe.
Hofman A
Eur J Epidemiol; 1991 Sep; 7(5):466-8. PubMed ID: 1761104
[TBL] [Abstract][Full Text] [Related]
15. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
[TBL] [Abstract][Full Text] [Related]
16. Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK.
Hall V; Brookes D; Nacul L; Gill ON; Connor N;
J Hosp Infect; 2014 Sep; 88(1):22-7. PubMed ID: 25082752
[TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease and the risk from blood or blood products.
Will RG; Kimberlin RH
Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
[TBL] [Abstract][Full Text] [Related]
18. The new variant of the Creutzfeldt-Jakob disease accounts for no relative increase of the Creutzfeldt-Jakob disease mortality rate in the United Kingdom; this fits ill with the new variant being the consequence of consumption of food infected with the agent of Bovine Spongiform Encephalopathy.
Laprevotte I; Hénaut A
BMC Public Health; 2003 Aug; 3():25. PubMed ID: 12901737
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of Creutzfeldt-Jakob disease in France, 1992-1995].
Ruffié A; Delasnerie-Lauprêtre N; Brandel JP; Jaussent I; Dormont D; Laplanche JL; Hauw JJ; Richardson S; Alpérovitch A
Rev Epidemiol Sante Publique; 1997 Dec; 45(6):448-53. PubMed ID: 9496575
[TBL] [Abstract][Full Text] [Related]
20. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
